Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication

• Status: Completed
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To collect the efficacy and safety information of fluconazole on infant subjects related to their appropriate use in daily practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Fluconazole

Criteria

Inclusion Criteria:

• Male or Female under age of seven patients who are prescribed fluconazole (Diflucan) for antifungal treatment or prophylaxis administration.

Exclusion Criteria:

• Subject of seven years or more who have been prescribed fluconazole.